CrystecPharma is delighted to announce that our Commercial Director, Steven Nicholson, has been selected as a finalist in the Future Leader category at the CPHI Pharma Awards 2026.
The CPHI Pharma Awards recognise individuals and organisations driving innovation, leadership and positive change across the global pharmaceutical industry. Steven’s nomination reflects his commitment to CrystecPharma’s continued growth, the development of valuable industry partnerships and the advancement of our proprietary mSAS® particle-engineering technology.
The winner will be revealed during the CPHI Celebration Happy Hour in Milan on 6 October 2026.
Steven and the wider CrystecPharma team will be attending CPHI Milan from 6–8 October. If you are attending and would like to learn more about mSAS® or discuss a potential collaboration, we would be pleased to arrange a meeting.
Congratulations to Steven and all the other finalists.